LNC
AZN icon

Lincoln National Corp’s AstraZeneca AZN Stock Holding History

Lincoln National Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,500
Closed -$2.51M – 100
2024
Q1 		$2.51M Buy
18,500
+2,137
+13% +$283K 0.04% 281
2023
Q4 		$2.2M Buy
16,363
+449
+3% +$58.4K 0.04% 270
2023
Q3 		$2.16M Buy
15,914
+477
+3% +$65.1K 0.04% 233
2023
Q2 		$2.21M Buy
15,437
+609
+4% +$89.6K 0.04% 232
2023
Q1 		$2.06M Buy
14,828
+1,423
+11% +$191K 0.04% 226
2022
Q4 		$1.82M Sell
13,405
-2,106
-14% -$264K 0.04% 238
2022
Q3 		$1.7M Buy
15,511
+301
+2% +$38.2K 0.04% 234
2022
Q2 		$2.01M Sell
15,210
-278
-2% -$36.5K 0.05% 209
2022
Q1 		$2.06M Buy
15,488
+427
+3% +$51.2K 0.04% 224
2021
Q4 		$1.75M Sell
15,061
-242
-2% -$28.5K 0.04% 240
2021
Q3 		$1.84M Buy
15,303
+8,460
+124% +$985K 0.04% 216
2021
Q2 		$819K Buy
6,843
+1,040
+18% +$114K 0.02% 360
2021
Q1 		$577K Buy
5,803
+124
+2% +$12.5K 0.01% 426
2020
Q4 		$568K Buy
5,679
+317
+6% +$33.6K 0.02% 387
2020
Q3 		$588K Buy
5,362
+464
+9% +$51.6K 0.02% 350
2020
Q2 		$518K Buy
4,898
+1,164
+31% +$120K 0.02% 367
2020
Q1 		$333K Buy
3,734
+1,372
+58% +$129K 0.01% 424
2019
Q4 		$235K Buy
+2,362
New +$222K 0.01% 557
2019
Q3 		– Sell
-2,949
Closed -$243K – 580
2019
Q2 		$243K Buy
+2,949
New +$231K 0.01% 475

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Lincoln National Corp's AZN Position: Q2 2024 in Review

Lincoln National Corp sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 18,500 shares — an estimated $2.51M sold.

Lincoln National Corp first reported a position in AZN in Q2 2019 and held it in 19 quarters. The position peaked at $2.51M in Q1 2024. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Lincoln National Corp reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 18,500 AstraZeneca shares in Q2 2024, an estimated $2.51M.
  • Lincoln National Corp first reported a position in AstraZeneca in Q2 2019 and held it in 19 quarters.
  • Lincoln National Corp's AstraZeneca position peaked at $2.51M in Q1 2024.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.